Table 2. Labor and delivery factors in women delivered for hypertensive disorder of pregnancy.
Readmitteda (n = 25) | Not readmitted (n = 74) | P-value | |
---|---|---|---|
GA (weeks) at time of diagnosis | 35.4 (±4) | 35.3 (±3.6) | 0.90 |
Peak systolic BP recorded on admission note (mm Hg) | 165.4 (±22.1) | 164 (±19.3) | 0.76 |
Peak diastolic BP recorded on admission note (mm Hg) | 101 (±16.9) | 99.5 (±12.2) | 0.62 |
Severity of PRE | 0.39 | ||
GHTN | 4 (16) | 11 (14.9) | |
Mild PRE | 1 (4) | 1 (1.4) | |
Severe PRE | 14 (56) | 40 (54.1) | |
HELLP | 3 (12) | 13 (18) | |
Superimposed PRE | 3 (12) | 8 (10.8) | |
Eclampsia | 0 (0) | 1 (0.01) | |
Labor induction/augmentation | 17 (68) | 50 (67.57) | 0.97 |
Vaginal delivery | 8 (47) | 28 (56) | 0.52 |
Cesarean delivery | 9 (53) | 22 (44) | |
Overall cesarean delivery | 15 (60) | 36 (48.7) | 0.33 |
Number of IV antihypertensive doses given before deliveryb | 1.6 (±1.4) | 1.5 (±1.3) | 0.76 |
Intravenous fluidsc | |||
Fluid balance (cc) | 1182.9 (±1861.2) | 575.4 (±2193.0) | 0.22 |
Total pre-delivery input (cc) | 3780.2 (±2301.5) | 3851.0 (±2995.6) | 0.91 |
Lab abnormalitiesd | 16 (64) | 49 (66.2) | 0.84 |
Use of magnesium sulfate in labor and 24 h post partum | 20 (80) | 64 (86.4) | 0.55 |
Abbreviations: ALT, alanine transaminase; AST, aspartate aminotransferase; BP, blood pressure; Cr, creatinine; GA, gestational age; GHTN, gestational hypertension; HELLP, hemolysis, elevated liver enzymes, low platelets; plt, platelet; PRE, preeclampsia. Categorical data: n (%). Continuous data: mean (s.d.).
Readmitted= postpartum hypertension readmissions within 4 weeks of discharge.
If received BP medication.
Fluid balance=intravenous fluids in (labor intravenous fluids +cesarean intraop intravenous fluids)– output (estimated blood loss, labor urine output+CD urine output); total pre-delivery intravenous fluids=labor intravenous fluids+cesarean intraop intravenous fluids.
Lab abnormalities=any of the following: Plt <100 thousand μl−1, Cr >1.0 mg dl−1, AST >45 U l−1, ALT >60 U l−1.